(3aS,4R,6R,9S,10S,11aR)-9-methoxy-6,10-dimethyl-3-methylene-2-oxododecahydro-6,9-epoxycyclodeca[b]furan-4-yl isobutyrate

Catalog No. :
ACQEBQ160
CAS No. :
1021945-29-8
Molecular Formula :
C20H30O6
Molecular Weight :
366.45

IUPAC Name:(3aS,4R,6R,9S,10S,11aR)-9-methoxy-6,10-dimethyl-3-methylene-2-oxododecahydro-6,9-epoxycyclodeca[b]furan-4-yl isobutyrate

(3aS,4R,6R,9S,10S,11aR)-9-methoxy-6,10-dimethyl-3-methylene-2-oxododecahydro-6,9-epoxycyclodeca[b]furan-4-yl isobutyrate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3aS,4R,6R,9S,10S,11aR)-9-methoxy-6,10-dimethyl-3-methylene-2-oxododecahydro-6,9-epoxycyclodeca[b]furan-4-yl isobutyrate
IUPAC Name(3aS,4R,6R,9S,10S,11aR)-9-methoxy-6,10-dimethyl-3-methylene-2-oxododecahydro-6,9-epoxycyclodeca[b]furan-4-yl isobutyrate
Molecular FormulaC20H30O6
Molecular Weight366.45
SMILESC=C1C(=O)O[C@@H]2C[C@H](C)[C@]3(OC)CC[C@](C)(C[C@@H](OC(=O)C(C)C)[C@@H]12)O3
InChI KeySOLCYTMIFQPNDN-IZEBJNRDSA-N
Synonym3-O-Methyltirotundin;Propanoic acid, 2-methyl-, (3aS,4R,6S,9S,10S,11aR)-dodecahydro-9-methoxy-6,10-dimethyl-3-methylene-2-oxo-6,9-epoxycyclodeca[b]furan-4-yl ester
CAS No.1021945-29-8

Synthetic Route by SureRoute

1. ACQEBQ160 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQEBQ160 route product structure diagram
    ACQEBQ1601021945-29-8
Inquiry

2. ACQEBQ160 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACICVF063 route compound structure diagram
    ACICVF06315432-56-1 In Stock
  4. Then
  5. ACQEBQ160 route product structure diagram
    ACQEBQ1601021945-29-8
Inquiry

Comments (0)